National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis

医学 性病学 特应性皮炎 湿疹面积及严重程度指数 疾病 生活质量(医疗保健) 人口 皮肤科生活质量指数 皮肤病科 内科学 钙调神经磷酸酶 杜皮鲁玛 移植 环境卫生 护理部
作者
Niccolò Gori,Andrea Chiricozzi,Franco Marsili,Silvia Ferrucci,Paolo Amerio,Vincenzo Battarra,Salvatore Campitiello,Antonio Castelli,Maurizio Congedo,Monica Corazza,Antonio Cristaudo,Gabriella Fabbrocini,Giampiero Girolomoni,Giovanna Malara,Giuseppe Micali,Giovanni Palazzo,Aurora Parodi,Annalisa Patrizi,Giovanni Pellacani,Paolo D. Pigatto
出处
期刊:Journal of Clinical Medicine [Multidisciplinary Digital Publishing Institute]
卷期号:11 (17): 5204-5204 被引量:10
标识
DOI:10.3390/jcm11175204
摘要

Atopic dermatitis (AD) is a common inflammatory skin disease often associated with a significant impairment in the quality of life of affected patients. The Italian Society of Dermatology and Venereology (SIDeMaST) planned a national information campaign, providing direct access to 27 dermatologic centers dedicated to the management of AD. The aim of this study aimed was to outline critical aspects related to AD in the general population. Overall, 643 adult subjects were included in this study, and in 44.2% (284/643) of cases, a diagnosis of AD was confirmed, whereas about 55% of subjects were affected by other pruritic cutaneous diseases. Higher intensity of pruritus and sleep disturbance, as well as an increased interference in sport, work, and social confidence was reported in the AD group compared to the non-AD group. In the AD subgroup, the mean duration of disease was of 15.3 years, with a mean eczema area and severity index (EASI) score of 11.2, and investigator global assessment (IGA) score of 1.9 and an itch numeric rating scale (NRS) of 6.9. Almost 32% of patients were untreated, either with topical or systemic agents, whereas 44.3% used routine topical compounds (topical corticosteroids and calcineurin inhibitors), and only 7.0% of patients were systemically treated. Only 2.8% of patients reported complete satisfaction with the treatment received for AD to date. This study reveals a profound unmet need in AD, showing a poorly managed and undertreated patient population despite a high reported burden of disease. This suggests the usefulness of information campaigns with the goal of improving patient awareness regarding AD and facilitating early diagnosis and access to dedicated healthcare institutions.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
a410731466完成签到,获得积分10
1秒前
FashionBoy应助舒心的南珍采纳,获得10
1秒前
不会摸鱼的研究生不是好研究生完成签到 ,获得积分10
1秒前
郭盾完成签到,获得积分10
2秒前
lucia5354完成签到,获得积分0
2秒前
晓风残月完成签到,获得积分10
2秒前
科研小白发布了新的文献求助10
2秒前
无极微光应助rabpig采纳,获得20
3秒前
汤姆完成签到,获得积分10
3秒前
仙女完成签到 ,获得积分10
3秒前
能干的cen完成签到,获得积分10
3秒前
优秀含羞草完成签到,获得积分10
3秒前
4秒前
西柚完成签到,获得积分10
4秒前
4秒前
郭盾发布了新的文献求助10
4秒前
阿菜想毕业了完成签到,获得积分20
5秒前
yangyang发布了新的文献求助10
5秒前
橙子快跑发布了新的文献求助10
5秒前
perfect完成签到 ,获得积分10
6秒前
李健的小迷弟应助loc1101采纳,获得10
6秒前
太浮躁完成签到,获得积分10
6秒前
冷傲的如柏完成签到,获得积分10
6秒前
神经娃完成签到,获得积分10
7秒前
MiriamYu完成签到,获得积分10
7秒前
7秒前
7秒前
8秒前
巧克力豆丁好好吃完成签到,获得积分10
8秒前
王佳豪完成签到,获得积分10
8秒前
lm完成签到,获得积分10
8秒前
了111完成签到,获得积分10
10秒前
Tiscen发布了新的文献求助10
10秒前
活力鸡完成签到,获得积分10
10秒前
研究啥完成签到,获得积分10
10秒前
顺顺顺完成签到 ,获得积分10
10秒前
在水一方应助辛勤的翠桃采纳,获得10
11秒前
xiaojiu发布了新的文献求助10
11秒前
瞿访云完成签到,获得积分10
12秒前
12秒前
高分求助中
Adhesion Science: Principles & Practice 1234
Cold War Transcended: Australia's China Policy, 1949-1990 998
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
Testimonial Injustice and Trust 510
Burger's Medicinal Chemistry and Drug Discovery 400
Fundamentals of Body MRI 3rd Edition 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6639656
求助须知:如何正确求助?哪些是违规求助? 8397217
关于积分的说明 17954960
捐赠科研通 5826826
什么是DOI,文献DOI怎么找? 2967678
邀请新用户注册赠送积分活动 1942540
关于科研通互助平台的介绍 1858293